Abstract
Mental health issues such as depression and anxiety are common comorbidities of individuals suffering from chronic respiratory disorders. Anxiety & Depression decreases the quality of life of these affected individuals by altering their function of daily living (affecting physical, emotional, and social roles), increasing mortality and healthcare utilization. The management of co-morbid neuropsychological conditions demands a thorough knowledge of pathophysiology and subtle nuances of general and psychopharmacology, along with clinical knowledge knitted with soft skills. There is positive evidence of neuropsychiatric benefits from pulmonary rehabilitation, especially improved mood, and cognitive performance. Further research is needed to examine the effects of specific components of PR on the neuropsychological function of these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Emery CF, Green MR, Suh S. Neuropsychiatric function in chronic lung disease: the role of pulmonary rehabilitation. Respir Care. 2008;53:1208.
Yohannes AM. Depression and anxiety in patients with interstitial lung disease. Expert Rev Respir Med. 2020;14:859. https://www.tandfonline.com/action/journalInformation?journalCode=ierx20. Accessed 22 Jun 2022.
Lee YJ, Choi SM, Lee YJ, Cho YJ, Yoon HI, Lee JH, et al. Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis. PLoS One. 2017;12(9):e0184300. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0184300. Accessed 22 Jun 2022.
Porzelius J, Vest M, Nochomovitz M. Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients. Behav Res Ther. 1992;30(1):75–7.
Baker AM, Holbrook JT, Yohannes AM, Eakin MN, Sugar EA, Henderson RJ, et al. Test performance characteristics of the AIR, GAD-7, and HADS-anxiety screening questionnaires for anxiety in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2018;15(8):926–34. www.atsjournals.org. Accessed 23 Jun 2022.
Montserrat-Capdevila J, Godoy P, Marsal JR, Barbé F, Pifarré J, Alsedà M, et al. Overview of the impact of depression and anxiety in chronic obstructive pulmonary disease. Lung. 2017;195(1):77–85. https://pubmed.ncbi.nlm.nih.gov/27900466/. Accessed 23 Jun 2022.
Deng D, Zhou A, Chen P, Shuang Q. CODEXS: a new multidimensional index to better predict frequent COPD exacerbators with inclusion of depression score. Int J COPD. 2020;15:249–59.
Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43S–56S. https://pubmed.ncbi.nlm.nih.gov/18842932/. Accessed 23 Jun 2022.
Giannouli V, Markopoulou A, Kiosseoglou G, Kosmidis MH. Neuropsychological functioning in patients with interstitial lung disease. Appl Neuropsychol Adult. 2021;29:1290. https://www.tandfonline.com/doi/abs/10.1080/23279095.2020.1870465. Accessed 26 May 2022.
Akhtar AA, Ali MA, Smith RP. Depression in patients with idiopathic pulmonary fibrosis. Chron Respir Dis. 2013;10(3):127–33.
Ryerson CJ, Arean PA, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, et al. Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology. 2012;17(3):525–32.
del Barrio V. Diagnostic and statistical manual of mental disorders. Encyclopedia of applied psychology, Three-Volume Set. Washington, DC: American Psychiatric Association; 2004. p. 607–14.
Grant I, Prigatano GP, Heaton RK, McSweeny AJ, Wright EC, Adams KM. Progressive neuropsychologic impairment and hypoxemia. Relationship in chronic obstructive pulmonary disease. Arch Gen Psychiatry. 1987;44(11):999–1006. https://pubmed.ncbi.nlm.nih.gov/3675139/. Accessed 23 Jun 2022.
Ozge C, Ozge A, Unal O. Cognitive and functional deterioration in patients with severe COPD 1. Behav Neurol. 2006;17:121–30.
Stuss DT, Peterkin I, Guzman DA, Guzman C, Troyer AK. Chronic obstructive pulmonary disease: effects of hypoxia on neurological and neuropsychological measures. J Clin Exp Neuropsychol. 1997;19(4):515–24. https://pubmed.ncbi.nlm.nih.gov/9342687/. Accessed 23 Jun 2022.
Li J, Fei GH. The unique alterations of hippocampus and cognitive impairment in chronic obstructive pulmonary disease. Respir Res. 2013;14(1):140.
Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010;25(12):1209–21.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kumari, S., Kumar, K., Narasimhan, M. (2023). Neuropsychiatric Disorders in Pulmonary Rehabilitation. In: Esquinas, A.M., Fabbo, A., Koc, F., Prymus, A., Farnik, M. (eds) Noninvasive Mechanical Ventilation and Neuropsychiatric Disorders . Springer, Cham. https://doi.org/10.1007/978-3-031-27968-3_31
Download citation
DOI: https://doi.org/10.1007/978-3-031-27968-3_31
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-27967-6
Online ISBN: 978-3-031-27968-3
eBook Packages: MedicineMedicine (R0)